News

23 May 2011

Celladon Corporation Announces MYDICAR® Enzyme Replacement Therapy for Advanced Heart Failure Provides Sustained Reduction in Clinical Events in Patients for 18 Months Compared with Placebo

Read full story

19 May 2011

Metabolex Initiates Phase 2 Trial Of Arhalofenate

Read full story

11 May 2011

Light Sciences Oncology Elects Dennis Langer, M.D., J.D. to Its Board of Directors

Read full story

4 May 2011

Allergan and Molecular Partners Enter into an Exclusive License Agreement For MP0112 For the Treatment of Retinal Diseases

Read full story